VORSCHAU
Frühere Meldungen
PRESSETERMINE
AKTUELLES PRESSEFOTO
IR Nachrichten
06.05.2024 11:00
MS Industrie AG
06.05.2024 10:38
Nexus AG
05.05.2024 09:00
Small- & MicroCap Investment
EUROPA NACHRICHTEN
ADHOC
Mo, 21.12.2020 22:30
pta20201221047
Business news for the stock market
Medigene AG: Participation at upcoming virtual conferencesPlanegg/Martinsried (pta047/21.12.2020/22:30) - 21 December 2020. Medigene AG (Medigene, FSE: MDG1, Prime Standard), a clinical stage immuno-oncology company focusing on the development of T cell immunotherapies, will participate at the following upcoming scientific and investor conferences. Please note that all mentioned conferences will be conducted virtually due to COVID-19 pandemic.
LifeSci Advisors Corporate Access Event
TCT
|
Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR
CAR-TCR Europe
Immuno-Oncology 360°
--- end of press release ---
About Medigene
This press release contains forward-looking statements representing the opinion of Medigene as of the date of this release. The actual results achieved by Medigene may differ significantly from the forward-looking statements made herein. Medigene is not bound to update any of these forward-looking statements. Medigene® is a registered trademark of Medigene AG. This trademark may be owned or licensed in select locations only.
Medigene
In case you no longer wish to receive any information about Medigene, please inform us by e-mail (investor@medigene.com). We will then delete your address from our distribution list. (Ende)
FOTODIENST
PRESSETEXT.TV
Walter Oblin sieht Post auf Wachstumskurs 18.04.2023 ETARGET
FOCUSTHEMA
SPECIALS
Werbung
middleAdvertising
|